| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,945 |
15,392 |
$2.79M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,696 |
7,112 |
$2.52M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,369 |
2,158 |
$131K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
502 |
485 |
$93K |
| 80053 |
Comprehensive metabolic panel |
5,042 |
4,414 |
$72K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,351 |
2,243 |
$68K |
| 71045 |
Radiologic examination, chest; single view |
4,360 |
4,059 |
$54K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,676 |
2,000 |
$39K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
650 |
581 |
$28K |
| 36415 |
Collection of venous blood by venipuncture |
13,461 |
12,187 |
$27K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
273 |
261 |
$21K |
| 85027 |
|
8,447 |
7,375 |
$20K |
| 70450 |
Computed tomography, head or brain; without contrast material |
765 |
709 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
582 |
577 |
$16K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
372 |
334 |
$15K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
53 |
53 |
$11K |
| 84484 |
|
1,820 |
1,247 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
762 |
738 |
$10K |
| 83880 |
|
751 |
676 |
$8K |
| 81001 |
|
2,074 |
1,922 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,318 |
1,169 |
$5K |
| 83690 |
|
2,144 |
1,944 |
$4K |
| 87070 |
|
502 |
484 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
159 |
152 |
$3K |
| 84703 |
|
696 |
651 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,774 |
1,591 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12 |
12 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
302 |
252 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
63 |
63 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
975 |
835 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
84 |
77 |
$987.50 |
| 81003 |
|
356 |
333 |
$973.81 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
64 |
64 |
$766.75 |
| 85730 |
|
1,005 |
908 |
$702.91 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
44 |
41 |
$620.59 |
| 86850 |
|
28 |
27 |
$605.88 |
| 85610 |
|
1,144 |
1,027 |
$583.19 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
513 |
295 |
$450.50 |
| 84702 |
|
33 |
29 |
$391.84 |
| 83605 |
|
205 |
182 |
$372.77 |
| 87040 |
|
193 |
130 |
$347.11 |
| 87420 |
|
29 |
29 |
$265.96 |
| 83735 |
|
363 |
309 |
$257.22 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
143 |
79 |
$182.29 |
| 82150 |
|
82 |
76 |
$176.99 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
192 |
187 |
$135.25 |
| 84100 |
|
248 |
224 |
$80.52 |
| 86900 |
|
48 |
45 |
$77.81 |
| 86901 |
|
48 |
45 |
$77.81 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
56 |
51 |
$29.88 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
50 |
38 |
$29.04 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37 |
36 |
$18.75 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
151 |
138 |
$16.78 |
| J3490 |
Unclassified drugs |
89 |
70 |
$2.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$0.62 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
248 |
235 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
29 |
28 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
42 |
41 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
288 |
272 |
$0.00 |
| A9270 |
Non-covered item or service |
862 |
553 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
17 |
14 |
$0.00 |